Drug to slow bleeding leads to more deaths: study | Health | Reuters.com

Drug to slow bleeding leads to more deaths: study Health Reuters.com: "Based on five years of data on 3,876 heart bypass patients from around the world, the death rate among the 1,072 patients given Bayer AG's drug aprotinin was nearly 21 percent, two-thirds higher than the mortality rate among surgery patients not given anti-bleeding drugs."

This drug has the ability to start clots. Its use seems to run against common sense in a situation always trying to eliminate them.